Kenya ranks 44th in type 1 diabetes among children and youth, new report shows

The article refers to the Foundation’s new report, highlighting a crisis in Africa where an estimated 1.2 million children and young people (CYP) are living with diabetes, with around 150,000 new cases of type 1 diabetes (T1D) diagnosed annually — figures likely underestimated due to gaps in diagnostic services. 

Kenya’s ranking as the 44th highest country worldwide for T1D prevalence among CYP underscores the significant challenges in managing this chronic condition. The article highlights the report’s focus on limited access to essential diabetes care products, including insulin and blood glucose monitoring devices, especially in rural and underserved areas. 

“Hundreds of thousands of children and young people in low- and middle-income countries face barriers to accessing essential insulin, supplies and care,” the article quotes Claudia Martínez, Director of Research at the Access to Medicine Foundation. “While the pharmaceutical industry is engaged in bridging access gaps, initiatives must prioritise sustainability and affordability to save lives.” 

Both the article and the report stress the urgent need for pharmaceutical companies, governments, and health partners to move beyond reliance on short-term donations and adopt sustainable strategies that improve affordability and access. Integrating diabetes care into national health plans, strengthening health education, and developing reimbursement systems are critical steps to ensure children and young people receive consistent, effective care.